Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 26 (1) , 76-82
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease controlLeukemia & Lymphoma, 2011
- Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine–melphalan conditioning for treatment of mature T-cell lymphomasBone Marrow Transplantation, 2011
- Update on treatment of cutaneous T-cell lymphomaCurrent Opinion in Oncology, 2009
- Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoidesBone Marrow Transplantation, 2007
- Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndromeBritish Journal of Dermatology, 2007
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimenBone Marrow Transplantation, 2003
- Prognostic factor analysis in mycosis fungoides/Sézary syndromeJournal of the American Academy of Dermatology, 1999
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986